Australia Therapeutic Goods Administration (TGA) Grants Provis...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., Jan. 20, 2022 /PRNewswire-AsiaNet/ -- Nuvaxovid(TM) is the first protein-based COVID-19 vaccine to receive approval for provisional registration in AustraliaNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines f...
Authors: LATEST ASIANET NEWS RELEASES